Basic information |
Metabolite name | Azelaic acid |
HMDB0000784 | |
C08261 | |
2266 | |
Synonyms | Azelate |
No. of studies | 16 |
Relationship between Azelaic acid and depression (count: 16) |
Study | Study Type | Comparison groups | Tissue | Organism | Up/Down regulated |
Study M006 | Type1 | depressed group vs. control group | Plasma | Human | Up |
Study M034 | Type1 | MDD group vs. control group | Urine | Human | Up |
Study M070 | Type1 | depressed group vs. non-depressed group | Urine | Human | Up |
Study M096 | Type1 | CUMS group vs. control group | Plasma | Wistar rat | Down |
Study M096 | Type2 | CUMS + paroxetine group vs. CUMS group | Plasma | Wistar rat | Up |
Study M097 | Type1 | depressed women group vs. control women group | Urine | Human | Up |
Study M102 | Type1 | moderate MDD group vs. control group | Urine | Human | Up |
Study M464 | Type1 | drug-naive MDD group vs. control group | Plasma | Human | Up |
Study M464 | Type1 | drug-treatment MDD group vs. control group | Plasma | Human | Up |
Study M475 | Type1 | dHB group vs. HB group | Urine | Human | Up |
Study M480 | Type1 | sleep deprivation group vs. control group | Urine | Wistar rat | Up |
Study M668 | Type1 | PSD group vs. stroke group | Urine | Human | Down |
Study M686 | Type1 | depression group vs. control group | Urine | Human | Down |
Study M757 | Type1 | PSD group vs. stroke group | Urine | Human | Up |
Study M850 | Type1 | reserpine group vs. control group | Brain | C57BL/6 mouse | Up |
Study M905 | Type1 | subclinical depression group vs. control group | Urine | Human | Down |
Study M911 | Type1 | CUS group vs. control group | Serum | Sprague-Dawley rat | Down |
Study M956 | Type1 | CUMS group vs. control group | Faece | C57BL/6J mouse | Up |
Study M956 | Type2 | CUMS + deoiled sunflower seeds group vs. CUMS group | Faece | C57BL/6J mouse | Down |
Study M956 | Type2 | CUMS + whey protein-based group vs. CUMS group | Faece | C57BL/6J mouse | Down |